mediguide4u logo
mediguide4u
NavigationHomeAbout UsHealth GuidesHealth ToolsQuizzesMedical BoardFAQContact
Account
LoginRegister
N
Physician ReviewerMBBS, MD, PhD (Cantab), FAMS

Dr. Nikhil Tandon, MBBS, MD, PhD, FAMS

Professor & Head, Department of Endocrinology & Metabolism, AIIMS New Delhi

License VerifiedActive & In Good Standing

ID: DMC-09144

Delhi Medical Council (DMC) & Medical Council of India (MCI)

Professional Background & Bio

Dr. Nikhil Tandon is Professor and Head of the Department of Endocrinology and Metabolism at the All India Institute of Medical Sciences (AIIMS), New Delhi. Recipient of the Padma Shri award, he is a leading international researcher in cardiometabolic health, diabetes epidemiology, and clinical trials.

Medical Specialization

Endocrinology, Diabetes Epidemiology, Insulin Resistance, Childhood Diabetes

Clinical Experience

30+ Years Academic Medicine & Clinical Endocrinology

Hospital / Clinical Affiliation

Professor & Head, Department of Endocrinology & Metabolism, AIIMS, Ansari Nagar, New Delhi

Education & Medical Training
  • PhD in Endocrinology - University of Cambridge, United Kingdom
  • MD in Internal Medicine - All India Institute of Medical Sciences (AIIMS), New Delhi
  • MBBS - AIIMS, New Delhi
Professional Profiles
AIIMS New Delhi Faculty DirectoryPubMed Research Index

Academic Thesis & Medical Research

450+ Scientific Publications & Cochrane Systematic Reviews
Postgraduate Thesis / Dissertation Title:

“Genetics and Immunological Markers of Autoimmune Thyroid Diseases and Insulin Resistance in South Asians”

Institution: University of Cambridge (United Kingdom) & AIIMS New Delhi

Doctor of Philosophy (PhD) doctoral thesis at Cambridge University investigating human leukocyte antigen (HLA) susceptibility loci, phenotypic expression of cardiometabolic syndrome, and childhood obesity genetics.

Key Investigative & Clinical Research Domains:
• Genetics of Type 2 Diabetes in South Asian Populations• Childhood Obesity, Insulin Resistance & Metabolic Syndrome• Autoimmune Thyroiditis & Polyclonal Antibody Profiling• Cardiovascular Disease Risk Prevention in Youth

Clinical Areas Reviewed for mediguide4u:

Prediabetes & Glycemic BiomarkersInsulin Sensitivity & Beta-Cell FunctionCardiometabolic Risk ReductionDiabetic Neuropathy & Nephropathy Prevention
Conflict-of-Interest & Editorial Independence Disclosure

Dr. Tandon reports zero industry sponsorships. Reviews are formulated strictly from clinical trial evidence and WHO/ADA guidelines.

Guides Medically Reviewed by Dr. Nikhil Tandon, MBBS, MD, PhD, FAMS

Verified for medical accuracy, safety guidelines, and clinical evidence.

7 Reviewed
Type 2 Diabetes: Clinical Diagnosis, HbA1c Cutoffs, Pharmacotherapy, and Remission ProtocolsDiabetes
2026-08-0810 min read

Type 2 Diabetes: Clinical Diagnosis, HbA1c Cutoffs, Pharmacotherapy, and Remission Protocols

Type 2 Diabetes is a progressive metabolic disorder characterized by peripheral insulin resistance and progressive pancreatic beta-cell dysfunction. Explore current American Diabetes Association (ADA) diagnostic standards, modern cardioprotective medications (GLP-1 RAs and SGLT2 inhibitors), continuous glucose monitoring (CGM), and clinical diabetes remission protocols.

Physician VerifiedRead Guide
Pre-Diabetes and Insulin Resistance: How to Lower Blood Glucose Before Type 2 DiabetesDiabetes
2026-08-089 min read

Pre-Diabetes and Insulin Resistance: How to Lower Blood Glucose Before Type 2 Diabetes

Prediabetes is a high-risk metabolic state affecting over 1 in 3 adults, characterized by peripheral insulin resistance and compensatory hyperinsulinemia. Explore clinical diagnostic cutoffs (HbA1c 5.7–6.4%, Fasting Glucose 100–125 mg/dL), HOMA-IR scoring, the landmark Diabetes Prevention Program (DPP) protocol, and skeletal muscle GLUT4 glucose disposal.

Physician VerifiedRead Guide
Diabetic Neuropathy: Early Nerve Pain Symptoms, Foot Exams, and Blood Sugar ControlDiabetes
2026-08-089 min read

Diabetic Neuropathy: Early Nerve Pain Symptoms, Foot Exams, and Blood Sugar Control

Diabetic Peripheral Neuropathy (DPN) is the most common chronic microvascular complication of diabetes, affecting up to 50% of diabetic patients over their lifetime. Explore the biochemical mechanisms of neural glucotoxicity (polyol pathway sorbitol accumulation, microvascular vasa nervorum ischemia), clinical 10-g Semmes-Weinstein monofilament exams, and pharmacological pain management.

Physician VerifiedRead Guide
Hypoglycemia (Low Blood Sugar): Symptoms, Rule of 15 Treatment, and Emergency CareDiabetes
2026-08-089 min read

Hypoglycemia (Low Blood Sugar): Symptoms, Rule of 15 Treatment, and Emergency Care

Hypoglycemia (blood glucose < 70 mg/dL) is an acute, potentially life-threatening endocrine emergency common in insulin- and sulfonylurea-treated diabetes. Explore the neuroendocrine response to falling glucose, autonomic vs. neuroglycopenic symptoms, the standardized clinical 'Rule of 15' treatment protocol, and emergency glucagon rescue.

Physician VerifiedRead Guide
Diabetic Retinopathy: Stages, Dilated Eye Exams, Microaneurysms, and Vision ProtectionDiabetes
2026-09-069 min read

Diabetic Retinopathy: Stages, Dilated Eye Exams, Microaneurysms, and Vision Protection

Diabetic retinopathy is a leading cause of preventable vision loss in working-age adults, caused by chronic microvascular damage to the retinal capillaries. Understand the stages of non-proliferative (NPDR) and proliferative (PDR) disease, diabetic macular edema (DME), and why annual dilated fundus examinations are essential before symptoms appear.

Physician VerifiedRead Guide